The Claim
In a mouse model of dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS), daily oral administration of 1 × 10⁹ CFU of Bifidobacterium longum subsp. longum BL21 for 8 weeks is associated with reduced weight gain, improved glucose tolerance, and lower area under the curve (AUC) in oral glucose tolerance tests compared to untreated PCOS mice, suggesting a modulatory effect on metabolic dysregulation in this animal model.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Giving a specific probiotic to mice with a condition similar to PCOS helped them gain less weight and process sugar better over 8 weeks.
See the scientific wording
In a mouse model of dihydrotestosterone (DHT)-induced polycystic ovary syndrome (PCOS), daily oral administration of 1 × 10⁹ CFU of Bifidobacterium longum subsp. longum BL21 for 8 weeks is associated with reduced weight gain, improved glucose tolerance, and lower area under the curve (AUC) in oral glucose tolerance tests compared to untreated PCOS mice, suggesting a modulatory effect on metabolic dysregulation in this animal model.
What the research says
1 studyThe study gave a specific probiotic to mice with PCOS for 8 weeks and found they gained less weight and handled sugar better, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.